Geron | GERN - Assets

Stock Price
1.52
Daily Change
0.01 0.33%
Monthly
14.77%
Yearly
-47.94%
Q1 Forecast
1.33

Geron reported $567.38M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Amgen USD 90.14B 2.24B Sep/2025
Bio Techne USD 2.53B 31.72M Sep/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Cytokinetics USD 1.44B 210.92M Sep/2025
Exelixis USD 2.82B 145.47M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
Geron USD 567.38M 12.18M Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
Incyte USD 6.33B 509M Sep/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025